ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Foundation offers funds for mesothelioma research.

July 9, 2004

“Forward Funding” Will Cost NCI $38 Million, 270 Grants, As OMB Legally Impounds FY 1985 Money

February 1, 1985

Oklahoma Cancer Center Recruits Four Professors.

June 15, 2001

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

February 17, 1989

QOL Of Anemic Patients Improved With Darbepoetin

June 28, 2002

The Clinical Cancer Letter To End Print Edition In 2010

November 27, 2009